Goldman Sachs Group Inc Oncolytics Biotech Inc Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 130,198 shares of ONCY stock, worth $161,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,198
Previous 109,098
19.34%
Holding current value
$161,445
Previous $60,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ONCY
# of Institutions
58Shares Held
1.46MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL207KShares$256,5560.01% of portfolio
-
Seeds Investor LLC New York, NY190KShares$235,5260.03% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$83,0040.0% of portfolio
-
Commonwealth Equity Services, LLC65.1KShares$80,7410.0% of portfolio
-
Franklin Resources Inc San Mateo, CA63.3KShares$78,4610.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $71.8M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...